IF THERE IS RENAL SYMPTOMATIC HYPERTENSION ! WHAT ARE SPECIFIC METHODS OF ITS TREATMENT?
https://doi.org/10.24884/1561-6274-2004-8-3-100-104
Abstract
About the Author
B. I. ShulutkoRussian Federation
References
1. Rosenthal T. Role of calcium channel blockers in the future, in view of the INSIGHT Study. Kidney Int 2002; 62 [Suppl 82]: S32
2. Klahr S, Morrissey J. Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage. Kidney Int 2002;. 62 [Suppl 82]: S23
3. FernandesVega F, Abellan J, Vegazo O et al. Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: Influence of hormone replacement therapy. Kidney Int 2002; 62 [Suppl 82]: S. 36
4. Лильин ЕТ, Богомазов ЕА, Гофман-Кадошников ПБ. Генетика для врачей. Медицина, М., 1990 5. Шулутко БИ. Артериальная гипертензия. Ренкор, СПб, 2000; 382
5. Шулутко БИ. Нефрология. Ренкор, СПб., 2002; 780
6. Шулутко БИ, Перов ЮЛ. Артериальная гипертензия. Лига, СПб, 1993; 304
7. Schmid M, Meyer S, Wegner R, Ritz E. Genetic risk of hypertension in glomerulonephritis. Kidney Int 1989; 36, Abstr: 319
8. Schmid M, Meyer S, Wegner R, Ritz E. Increased genetic risk of hypertension in glomerulonephritis? J Hypertens 1990; 8: 573578
9. Ланг ГФ. Гипертоническая болезнь. Медгиз, Л.,1950; 495 11. Мясников АЛ. Гипертоническая болезнь. Медгиз, М., 1954; 392
10. Volhard F, Fahr Th. Die Bright’she Nierenkranhait Klinik, Pathologie und Atlas. Springer, Berlin, 1914
11. Гогин ЕЕ. Синдром артериальной гипертонии как признак дезадаптационных нарушений. Клин мед 2002; (11): 411
Review
For citations:
Shulutko B.I. IF THERE IS RENAL SYMPTOMATIC HYPERTENSION ! WHAT ARE SPECIFIC METHODS OF ITS TREATMENT? Nephrology (Saint-Petersburg). 2004;8(3):100-104. (In Russ.) https://doi.org/10.24884/1561-6274-2004-8-3-100-104